James Paget University Hospitals NHS Foundation Trust

Specialist MDT: Norfolk and Norwich University Hospitals NHS Foundation Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Whole body MRI
    • One-stop diagnostic clinic
  • Treatment Facilities:
    • Chemotherapy
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS

Data Quality

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 214 712
Performance Status recorded 91% 62%
PSA completed 92% 40%
Gleason Score completed 83% 83%
TNM completed 76% 73%

Disease Presentation

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men with disease status determined 661 39897
Percentage of men diagnosed with metastatic disease 18% 17%

Management

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men diagnosed with low-risk localised disease 55 4684
Percentage of men with low-risk localised disease receiving radical treatment 4% 8%
No. of men diagnosed with locally advanced disease 287 15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment 72% 68%